Related Experiment Video
Updated: May 9, 2026
08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Fertility preservation and breast cancer: A complex problem
1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. Pmunster@medicine.ucsf.edu
Oncology (Williston Park, N.Y.)
|August 6, 2013
Summary
Young women diagnosed with breast cancer face fertility loss. Fertility preservation must be integrated into treatment decisions, especially with long-term hormonal therapies, to help patients weigh risks and benefits.
Area of Science:
- Oncology
- Reproductive Endocrinology
Background:
- Many women diagnosed with breast cancer are of reproductive age.
- Breast cancer treatment can lead to fertility impairment or loss.
- Fertility preservation is a critical consideration in treatment planning.
Purpose of the Study:
- To summarize current challenges and options for fertility preservation in women with breast cancer.
- To inform counseling for patients regarding risks and benefits of fertility preservation interventions.
Main Methods:
- Review of current literature on fertility preservation strategies.
- Analysis of challenges associated with estrogen receptor-positive breast cancer and hormonal therapy.
Main Results:
- Fertility preservation is complex, especially for estrogen receptor-positive breast cancer requiring ovarian function suppression.
- Extended hormonal therapy recommendations (up to 10 years) impact pregnancy timing.
- Understanding options and success rates is crucial for patient counseling.
Conclusions:
- Fertility preservation should be an integral part of breast cancer treatment planning for young women.
- Optimal patient counseling requires a thorough understanding of available fertility preservation options and their success likelihood.
- Balancing cancer treatment efficacy with fertility preservation is essential.
Related Concept Videos
01:28Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
01:23Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
01:41Spermatogenesis
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...